Joel Simrén
Impact in
- Psychiatry and Mental health top 2%
- Dementia and Cognitive Impairment Research
- Neurology top 5%
- Long-Term Effects of COVID-19
- Neuroinflammation and Neurodegeneration Mechanisms
- Traumatic Brain Injury and Neurovascular Disturbances
- Parkinson's Disease Mechanisms and Treatments
- Amyotrophic Lateral Sclerosis Research
Papers in ⓘ
- Physiology 19
- Alzheimer's disease research and treatments 19
-
- Dementia and Cognitive Impairment Research 17
- Co-authors
- Henrik Zetterberg (38 shared papers)Kaj Blennow (32 shared papers)Nicholas J. Ashton (28 shared papers)Thomas K. Karikari (11 shared papers)Juan Lantero‐Rodriguez (7 shared papers)Magnus Gisslén (4 shared papers)Arvid Edén (4 shared papers)Barbara Borroni (3 shared papers)
- Journals
- Alzheimer s & Dementia (10 papers)Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (3 papers)European Journal of Neurology (3 papers)Alzheimer s Research & Therapy (2 papers)Brain Communications (2 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Joel Simrén
42 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Psychiatry and Mental health 555
- Neurology 294
- Neurology 514
- Physiology 671
- Biological Psychiatry 60
Countries citing papers authored by Joel Simrén
This map shows the geographic impact of Joel Simrén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Simrén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Simrén more than expected).
Fields of papers citing papers by Joel Simrén
This network shows the impact of papers produced by Joel Simrén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Simrén. The network helps show where Joel Simrén may publish in the future.
Co-authors
The 25 scholars most cited alongside Joel Simrén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 140 | |
| 2 | Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change Hit paper breakdown → | 2022 | 134 |
| 3 | MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease Hit paper breakdown → | 2023 | 128 |
| 4 | Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 years Hit paper breakdown → | 2022 | 111 |
| 5 | 2021 | 109 | |
| 6 | 2020 | 102 | |
| 7 | 2021 | 76 | |
| 8 | 2019 | 67 | |
| 9 | 2022 | 62 | |
| 10 | 2021 | 60 | |
| 11 | 2020 | 59 | |
| 12 | 2022 | 49 | |
| 13 | 2023 | 47 | |
| 14 | 2021 | 47 | |
| 15 | 2022 | 47 | |
| 16 | 2020 | 37 | |
| 17 | 2023 | 32 | |
| 18 | 2024 | 26 | |
| 19 | 2022 | 23 | |
| 20 | 2024 | 21 |
About Joel Simrén
Joel Simrén is a scholar working on Physiology, Psychiatry and Mental health, Neurology, Molecular Biology and Neurology, having authored 44 papers that have together received 1.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (19 papers), Dementia and Cognitive Impairment Research (17 papers), Traumatic Brain Injury Research (6 papers), Long-Term Effects of COVID-19 (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), Intensive Care Unit Cognitive Disorders (5 papers), S100 Proteins and Annexins (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). The work is most often cited by research in Psychiatry and Mental health (555 citations), Neurology (294 citations), Neurology (514 citations), Physiology (671 citations) and Biological Psychiatry (60 citations). Joel Simrén has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Henrik Zetterberg, Kaj Blennow, Nicholas J. Ashton, Thomas K. Karikari, Juan Lantero‐Rodriguez, Magnus Gisslén, Arvid Edén, Barbara Borroni, Roberta Ghidoni and Eugeen Vanmechelen. Their work appears in journals such as Alzheimer s & Dementia, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, European Journal of Neurology, Alzheimer s Research & Therapy and Brain Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.